CEO SUMMARY: Advances in molecular and genetic science have generated the first generation of diagnostic assays for clinical use. As these assays reach the public, acceptance is not immediate. Obstacles are many: ethical, cultural, clinical, and economic. Oncormed’s experience during the last five years provides valuable insights about the challenges of being first to the […]
Genetic Testing Almost Accented In Market Place
Oncormed’s pioneering experiences illustrate that many hurdles still remain
- By Robert Michel
- > From the Volume V No. 12 - September 8, 1998 Issue
- Tags: aco, breast cancer test, cap, clinical lab, Clinical Laboratory, clinical laboratory industry, dark report, diagnostic assays, diagnostic testing, genetics test, genetics testing, genomics, informatics, laboratories, laboratory executive, laboratory industry, molecular profiling, pathologists, pharmacogenomics, test for breast cancer, the clinical laboratory, the dark report
